When there is a will to innovate, there is always a way! And when there is a way, it's our responsibility to make it happen.
Si nous voulons innover, nous pouvons le faire. Si nous pouvons innover, nous devons le faire.
Anaïs Barut is the CEO and one of the cofounders of DAMAE Medical, a start-up that develops early skin cancer detection techniques.
She is in charge of the relationships with the medical community and establishes the business model and the marketing, commercial and financing strategies. Ms Barut is a graduate of HEC Paris School of Management and of the Institut d’Optique Graduate School.
All along her curriculum, she got specialised in technological business and management with a focus on key success factors to drive disruptive medical innovations to market.
In 2016, she was also part of the Entrepreneurship track of the HEC Paris MBA programme. At 22, Ms Barut was awarded Youngest French Innovative CEO under 30, by the MIT Technology Review.
DAMAE Medical has benefitted from EU funding for a novel approach to non-invasive and personalised skin cancer diagnosis.
- Country: France
- Organisation: DAMAE Medical
- Social media: @Damae_medical
- References: CEO DAMAE Medical
- Category: Science, research and innovation